Genmab Cash Flow Statement 2018-2024 | GMAB

Fifteen years of historical annual cash flow statements for Genmab (GMAB).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$818$996$634$904$429$255
$42.83$51.26$39.46$39.68$20.84$13.88
$39.20$-33.84$-109.30$93.30$-10.34$-22.28
$82.04$17.42$-69.84$133$10.49$-8.41
$116$-313.36$-170.87$46.88$-248.53$-121.67
$-8.28$0$0$0$0$0
$0$0$0$0$0$0
$90.31$40.07$48.37$104$65.96$21.19
$198$-273.29$-122.51$151$-182.58$-100.48
$1,072$554$354$986$199$161
$-53.14$-44.89$-40.09$-47.03$-11.84$-11.36
$-1.45$0$0$0$-4.80$-64.26
$0$0$0$0$0$0
$-127.05$-340.55$-166.26$-313.14$-280.61$-205.95
$-4.50$-5.52$53.46$0$0$0
$-131.55$-346.07$-112.80$-313.14$-280.61$-205.95
$0$0$0$0$0$0
$-186.15$-390.96$-152.90$-360.17$-297.25$-281.56
$0$0$0$0$0$0
$-13.21$-10.34$-9.23$-6.74$-4.65$0
$-13.21$-10.34$-9.23$-6.74$-4.65$0
$-59.82$-88.92$-49.64$21.45$590$-11.23
$-59.82$-88.92$-49.64$21.45$590$-11.23
$0$0$0$0$0$0
$-14.96$-12.46$-7.96$-3.83$-37.03$0
$-87.99$-111.72$-66.82$10.88$549$-11.23
$722$133$270$568$453$-129.04
$85.09$62.16$49.32$30.64$22.04$14.38
$0$0$0$0$0$0